M P5 (Paroxetine Hydrochloride Extended-Release 37.5 mg)
Pill with imprint M P5 is Orange, Round and has been identified as Paroxetine Hydrochloride Extended-Release 37.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; generalized anxiety disorder; postmenopausal symptoms and belongs to the drug class selective serotonin reuptake inhibitors. excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M P5
Paroxetine Hydrochloride Extended-Release
- Imprint
- M P5
- Strength
- 37.5 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Selective serotonin reuptake inhibitors
- Pregnancy Category
- D - Positive evidence of risk - excluding Brisdelle, X - Not for use in pregnancy - Brisdelle
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2005 (Discontinued)
- Inactive Ingredients
-
ferrosoferric oxide,
silicon dioxide,
D&C Red No. 30,
FD&C Yellow No. 6,
lactose monohydrate,
soya lecithin,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polydextrose,
polysorbate 80,
propylene glycol,
sodium alginate,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate
Note: Inactive ingredients may vary.
Related Images for "M P5"
More about paroxetine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,414)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: selective serotonin reuptake inhibitors
Patient resources
- Drug Information
- Paroxetine (Advanced Reading)
- Paroxetine Controlled-Release Tablets
- Paroxetine Tablets
- Paroxetine Capsules
- Paroxetine Suspension
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.